SW
NMRA icon

SkyOak Wealth’s Neumora Therapeutics NMRA Stock Holding History

SkyOak Wealth’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Buy
150,000
+50,000
+50% +$130K 0.05% 183
2025
Q4 		$179K Hold
100,000
– – 0.03% 243
2025
Q3 		$182K Hold
100,000
– – 0.03% 242
2025
Q2 		$73.3K Buy
+100,000
New +$75.8K 0.01% 241
2025
Q1 		– Sell
-20,000
Closed -$212K – 262
2024
Q4 		$212K Buy
20,000
+5,000
+33% +$59.9K 0.05% 233
2024
Q3 		$198K Hold
15,000
– – 0.04% 226
2024
Q2 		$147K Buy
+15,000
New +$155K 0.03% 232

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return